ArticleMicrobiologyOpen2025
"Expanding the Lactococcal Cell Wall Polysaccharide Paradigm: Novel Structures and Metabolic Pathways in the Emerging Dairy Species Pseudolactococcus laudensis and Pseudolactococcus raffinolactis".
Article in MicrobiologyOpen, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative genomics and methylome profiling ofMicrobial genomics · 2026Article
- "Expanding the Lactococcal Cell Wall Polysaccharide Paradigm: Novel Structures and Metabolic Pathways in the Emerging Dairy Species Pseudolactococcus laudensis and Pseudolactococcus raffinolactis".MicrobiologyOpen · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Cell surface-associated polysaccharides, including cell wall polysaccharides (CWPSs), capsular polysaccharides (CPSs), and exopolysaccharides (EPSs), play vital roles in bacterial interactions with their environment, influencing critical aspects of dairy fermentations, such as phage-host dynamics. Pseudolactococcus laudensis and Pseudolactococcus raffinolactis (formerly Lactococcus laudensis and Lactococcus raffinolactis) are emerging dairy-associated species whose CWPSs remain uncharacterized. This study analyzed the complete genomes of 21 P. laudensis and seven P. raffinolactis strains to investigate the genetic diversity underlying CWPS and EPS production. Eight novel cwps genotypes (E-L) were identified, significantly expanding the known diversity within the dairy-associated (pseudo)lactococci. Notably, E and G genotypes diverge from the classical rhamnan-PSP organization, suggesting a CWPS biosynthesis pathway distinct from the dual-chain assembly found in previously studied Lactococcus. Additionally, eps loci were identified in 25 of the 28 strains, uncovering 11 distinct genotypes (I-XI) with evidence of horizontal gene transfer. Their integration into chromosomal genomic islands highlights their mobility and potential role in evolutionary adaptation. Chemical analysis revealed unprecedented CWPS structures. P. laudensis DSM 28961 (type E) presented a 6-deoxy-α-l-talan polysaccharide and a β-(1,4)-galactan, marking the first instance of d-talose replacing rhamnose and the first homopolysaccharide in (pseudo)lactococcal CWPS, respectively. These were structurally independent, confirming a novel CWPS organization and biosynthetic pathway. Conversely, P. raffinolactis DSM 20443 (type I) exhibited a typical rhamnan-PSP structure, composed of a variably glycosylated rhamnan and a glucose-lactose hexapolysaccharide, respectively. This study provides the first resolved CWPS structures for the Pseudolactococcus genus, expanding the understanding of polysaccharide biosynthesis in Lactic Acid Bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.